Clinical Updates

The U.S. House of Representatives has approved a ban on some patent agreements between brand name and generic drug… »   

Cutting pharmaceutical prices in the way European governments are doing now will severely reduce the number of new drugs making… »   

GlaxoSmithKline’s Avandia may face tougher scrutiny from a U.S. advisory panel reviewing whether the diabetes pill should be pulled from… »   

Doctors in the national capital are conducting clinical trials for a new diabetes drug which has the potential of… »   

Durham drug development company Tranzyme Pharma on Tuesday announced positive results in phase II clinical trials for a new stomach… »   

The diabetes drug rosiglitazone has been under intense scrutiny since a 2007 study in the New England Journal of Medicine… »   

An experimental drug from a promising new class of medicines significantly reduced blood sugar in patients with advanced type 2… »   

Two widely used diabetes medicines, Januvia and Byetta, pose no additional risk for cases of inflamed pancreas compared with other… »   

Former tennis prodigy Jennifer Capriati is recovering at a south Florida hospital from an accidental overdose of a prescription… »   

Procter & Gamble Co is recalling some units of a decongestant nasal spray sold at U.S. stores after finding that… »   

U.S. health regulators said on Friday they do not expect any shortage of children’s pain and allergy medications despite Johnson… »   

A U.S. advisory panel is set to review an experimental obesity-fighting drug from Orexigen Therapeutics Inc (OREX.O) in December, the… »   

MAP Pharmaceuticals Inc. said Wednesday it will present a new analysis showing its inhaled drug Levadex was effective in a… »   

“These studies are certainly very exciting, and suggest for the first time that certain antihypertensive drugs already available to the… »   

Giving just one-fifth the usual dose of the polio vaccine may protect babies against the virus nearly as well as… »